Not logged in
  Home   Markets   Shares   Funds   Portfolio   Toolbox   Charting   Alerts   Directory   
 Admin   

Tue 6 Aug 2024, 17:42 ASCENDIS HEALTH LIMITED - Appointment of the interim chief financial officer
Appointment of the interim chief financial officer

ASCENDIS HEALTH LIMITED
(Registration number 2008/005856/06)
(Incorporated in the Republic of South Africa)
Share code: ASC
ISIN: ZAE000185005
("Ascendis" or "the Company")


APPOINTMENT OF THE INTERIM CHIEF FINANCIAL OFFICER


Shareholders are hereby advised that Mrs Lihle Mbele ("Mrs Mbele"), a chartered accountant and the
current Group Head of Finance, has been appointed as the interim Chief Financial Officer ("Interim
CFO") of Ascendis with effect from 30 July 2024.

The Audit & Risk Committee has confirmed that Mrs Mbele is suitably qualified and has the appropriate
experience and expertise to assume the role and responsibility of Interim CFO.

The board congratulates Mrs Mbele and looks forward to her contribution as Interim CFO.

Johannesburg
6 August 2024

Sponsor
Valeo Capital (Pty) Ltd

Date: 06-08-2024 05:42:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
Other Profile Group sites: FundsData Online (unit trust data)  |  Profile Group corporate site
Terms of Use |  Privacy Policy |  PAIA manual |  FAQs/Help |  Site Map |  © Copyright Reserved 2026  ]
  


Powered by ProfileData


Follow us on: